180 related articles for article (PubMed ID: 12434558)
1. Metformin plus glyburide combination as initial therapy in type 2 diabetes: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():137-8. PubMed ID: 12434558
[No Abstract] [Full Text] [Related]
2. Metformin plus glyburide combination as therapy in failure to monotherapy in type 2 diabetic patients: one month follow-up.
Medina Santillán R; Reyes-García G; Mateos-García E
Proc West Pharmacol Soc; 2002; 45():139-40. PubMed ID: 12434559
[No Abstract] [Full Text] [Related]
3. Cardiovascular, metabolic and hormonal responses to the progressive exercise performed to exhaustion in patients with type 2 diabetes treated with metformin or glyburide.
Cunha MR; Silva ME; Machado HA; Fukui RT; Correia MR; Santos RF; Wajchenberg BL; Rocha DM; Rondon MU; Negrão CE; Ursich MJ
Diabetes Obes Metab; 2008 Mar; 10(3):238-45. PubMed ID: 18269639
[TBL] [Abstract][Full Text] [Related]
4. Glyburide/metformin (Glucovance) for type 2 diabetes.
Med Lett Drugs Ther; 2000 Nov; 42(1092):105-6. PubMed ID: 11077467
[No Abstract] [Full Text] [Related]
5. Transitioning patients with type 2 diabetes to a fixed combination > glyburide/metformin tablet.
Blonde L; Sandberg MI
Diabetes Technol Ther; 2000; 2(3):479-80. PubMed ID: 11467351
[No Abstract] [Full Text] [Related]
6. The effect of pioglitazone as add-on therapy to metformin or sulphonylurea compared to a fixed-dose combination of metformin and glibenclamide on diabetic dyslipidaemia.
Comaschi M; Corsi A; Di Pietro C; Bellatreccia A; Mariz S;
Nutr Metab Cardiovasc Dis; 2008 Jun; 18(5):373-9. PubMed ID: 17919894
[TBL] [Abstract][Full Text] [Related]
7. [Impact of intensive blood glucose control with hypoglycemic sulfamides, metformin or insulin on complications of non-insulin dependent diabetes].
André P
Rev Epidemiol Sante Publique; 1999 Mar; 47(1):93-5. PubMed ID: 10214683
[No Abstract] [Full Text] [Related]
8. Lowering effect on postprandial glycemic response of nopales added to Mexican breakfasts.
Bacardi-Gascon M; Dueñas-Mena D; Jimenez-Cruz A
Diabetes Care; 2007 May; 30(5):1264-5. PubMed ID: 17325260
[No Abstract] [Full Text] [Related]
9. [Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy].
González-Ortiz M; Martínez-Abundis E;
Rev Invest Clin; 2004; 56(3):327-33. PubMed ID: 15612515
[TBL] [Abstract][Full Text] [Related]
10. Choosing first-line therapy for management of type 2 diabetes.
Graber MA; Darby-Stewart A; Dachs R
Am Fam Physician; 2008 Jan; 77(1):16-7. PubMed ID: 18236820
[No Abstract] [Full Text] [Related]
11. Follow-up of intensive glucose control in type 2 diabetes.
Mühlhauser I
N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
[No Abstract] [Full Text] [Related]
12. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
De Mattia G; Laurenti O; Moretti A
Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
[TBL] [Abstract][Full Text] [Related]
13. Unsurpassed glycaemic control made simple.
Cardiovasc J S Afr; 2003; 14(5):288. PubMed ID: 14664235
[No Abstract] [Full Text] [Related]
14. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis.
Vanderpoel DR; Hussein MA; Watson-Heidari T; Perry A
Clin Ther; 2004 Dec; 26(12):2066-75. PubMed ID: 15823770
[TBL] [Abstract][Full Text] [Related]
15. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
Glueck CJ; Goldenberg N; Sieve L; Wang P
Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, tolerability and safety of nateglinide in combination with metformin. Results from a study under general practice conditions.
Schatz H; Schoppel K; Lehwalder D; Schandry R
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):262-6. PubMed ID: 12951631
[TBL] [Abstract][Full Text] [Related]
17. Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.
Brazg R; Xu L; Dalla Man C; Cobelli C; Thomas K; Stein PP
Diabetes Obes Metab; 2007 Mar; 9(2):186-93. PubMed ID: 17300594
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of intensive glucose control in type 2 diabetes.
Petrie JR
N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
[No Abstract] [Full Text] [Related]
19. [Fasting hyperglycemia and postprandial glucose peaks. Diabetes therapy mustact on 2 sides].
MMW Fortschr Med; 2003 Aug; 145(33-34):59. PubMed ID: 14526583
[No Abstract] [Full Text] [Related]
20. Apparent resolution of type 2 diabetes mellitus after initiation of potent antiretroviral therapy in a man from Africa with HIV infection.
Koeppe J; Kosmiski L
Clin Infect Dis; 2006 May; 42(10):e79-81. PubMed ID: 16619143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
